newsfilter
← Latest News
Business Wire·

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies that treat rare forms of cancer, granted stock options to six new employees as approved by the Compensation Committee of the Company's